Predictors of Curvature Improvement in Men with Peyronie's Disease Treated with Intralesional Collagenase Clostridium Histolyticum

Author:

Flores Jose M.1,Nascimento Bruno2,Punjani Nahid1,Salter Carolyn A.1,Bernie Helen L.1,Taniguchi Hisanori1,Miranda Eduardo1,Terrier Jean-Etienne1,Schofield Elizabeth3,Jenkins Lawrence1,Mulhall John P.1

Affiliation:

1. Sexual & Reproductive Medicine Program Urology Service Memorial Sloan Kettering Cancer Center , New York, NY , USA

2. Sexual & Reproductive Medicine ProgramUrology ServiceMemorial Sloan Kettering Cancer Center , New York, NY , USA

3. Department of Psychiatry and Behavioral Sciences Memorial Sloan Kettering Cancer Center , New York, NY , USA

Abstract

Abstract Introduction Penile curvature is the most common abnormality that is observed by men with Peyronie's disease (PD). Collagenase Clostridium histolyticum (CCH) has become a standard treatment for PD patients. Aim To identify predictor factors associated with improvements of penile curvature outcomes in men with PD treated with CCH. Methods We retrospectively collected the data of patients with PD treated with CCH up to 8 injections divided into 4 cycles between January 2014 and July 2020. Per protocol, penile curvature was assessed at baseline, and after the second and ford CCH cycle. If after cycle 2, curvature demonstrated no improvement, or penile curvature was significantly improved and the patient was happy, no further treatment was recommended. However, if penile curvature was significantly improved and the patient remained dissatisfied, 4 cycles were completed. Three categories of response were evaluated: improvement (≥10 degrees or ≥20%, either 1 happens), unchanged (±10 degrees or ±20%) or worsened (≥10 degrees or ≥20%, either 1 happens). Logistic regression analyses were performed to evaluate predictive factors associated with penile curvature improvements. Outcomes Degrees of the curvature changes between the baseline and after the cycles of CCH. Results A total of 114 patients underwent CCH treatment. Median age was 57 years. Median PD duration was 11 months. At baseline, mean curvature was 47 degrees, 65% had dorsal curvature, 53% mid-shaft location, and 15% calcification. After CCH treatment, the mean final curvature was 40 degrees. A total of 44% improved the curvature, 39% had no change while 17% worsened after CCH treatment. Of men who had penile curvature improvement with CCH treatment, the mean curvature decreasing in degrees and percentage were 22 degrees and 41%, respectively. Men with baseline curvature ≤ 30, 31–59, and ≥ 60 degrees, the percentage curvature improvement were 29%, 43%, and 60%, respectively. Baseline curvature was the only significant predictor of penile curvature improvement after CCH (OR 1.33, 95% CI = 1.1, 1.7). Clinical Implications We confirmed baseline penile curvature is the most important predictive factor, and this is the first report describing proportions of penile curvature improvement with CCH treatment. Strengths and Limitations This study has several strengths, including the use of validated instruments. Nonetheless, there are limitations: the retrospective nature of the study, a single institution; and modelling device was not controlled. Conclusion Penile curvature improvement was significantly more common in patients with greater baseline curvature, reaching up to 60% for patients with ≥ 60 degrees.

Funder

Sidney Kimmel Center for Prostate and Urologic Cancers

National Institutes of Health National Cancer Institute

Memorial Sloan Kettering Cancer Center

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

Reference20 articles.

1. An analysis of the natural history of Peyronie's disease;Mulhall;J Urol,2006

2. Risk factors for emotional and relationship problems in Peyronie's disease;Smith;J Sex Med,2008

3. Factors associated with erectile dysfunction and the Peyronie's disease questionnaire in patients with peyronie disease;Serefoglu;Urology,2017

4. Evidence-based management guidelines on Peyronie's disease;Chung;J Sex Med,2016

5. The clinical and psychosocial impact of Peyronie's disease;Levine;Am J Manag Care,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3